ReviewBiomedicines2021
Strategies Targeting Type 2 Inflammation: From Monoclonal Antibodies to JAK-Inhibitors.
Andrea Matucci et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this papercites it
ReviewBiomedicines2021
Andrea Matucci et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.